anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Antibodies

The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily. Additionally we are shipping TNFRSF8 Kits (34) and TNFRSF8 Proteins (21) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
TNFRSF8 943 P28908
TNFRSF8 21941 Q60846
TNFRSF8 25069 P97525
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-TNFRSF8 Antibodies at antibodies-online.com

Showing 10 out of 687 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated WB Anti-CD30 Picoband antibody,  All lanes: Anti-CD30 at 0.5ug/ml Lane 1: HELA Whole Cell Lysate at 40ug Lane 2: 293T Whole Cell Lysate at 40ug Lane 3: JURKAT Whole Cell Lysate at 40ug Predicted bind size: 67KD Observed bind size: 67KD 100 μg Log in to see 4 to 6 Days
$200.00
Details
Mouse Hamster FITC FACS 0.5 mg Log in to see 6 to 8 Days
$379.50
Details
Human Mouse Un-conjugated EIA, FACS, IHC (fro), IHC (p), IP, WB   0.1 mg Log in to see 6 to 8 Days
$434.50
Details
Human Mouse FITC FACS 50 μg Log in to see 6 to 8 Days
$346.50
Details
Human Rabbit Un-conjugated ELISA, IHC (p), IP, WB 100 μg Log in to see 20 to 21 Days
$218.90
Details
Mouse Rat PE FACS   100 Tests Log in to see 6 to 8 Days
$313.50
Details
Mouse Hamster Biotin FACS   0.5 mg Log in to see 6 to 8 Days
$379.50
Details
Human Mouse Un-conjugated FACS, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Flow cytometric analysis of Hela cells using CD30 mouse mAb (green) and negative control (red) . 100 μL Log in to see 2 to 3 Days
$430.10
Details
Human Rabbit FITC IF (p) Raji probed with CD30 Polyclonal Antibody, FITC Conjugated (bs-2495R-FITC) at 1:100 for 30 minutes compared to control cells (blue) and isotype control (orange). 100 μL Log in to see 14 to 21 Days
$405.90
Details
Human Mouse Un-conjugated FACS, IHC (p) Human Thymus (formalin-fixed, paraffin-embedded) stained with TNFRSF8 antibody LS-B1865 at 5 ug/ml followed by biotinylated anti-mouse IgG secondary antibody LS-D2, alkaline phosphatase-streptavidin and chromogen. 0.1 mg Log in to see 5 to 7 Days
$265.65
Details

TNFRSF8 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Mouse (Murine) , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,

Top referenced anti-TNFRSF8 Antibodies

  1. Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody for FACS - ABIN2689176 : Amakawa, Hakem, Kundig, Matsuyama, Simard, Timms, Wakeham, Mittruecker, Griesser, Takimoto, Schmits, Shahinian, Ohashi, Penninger, Mak: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. in Cell 1996 (PubMed)
    Show all 12 Pubmed References

  2. Human Monoclonal TNFRSF8 Primary Antibody for IHC (f), FACS - ABIN2749180 : Aalberse, Kapitein, de Roock, Klein, de Jager, van der Zee, Hoekstra, van Wijk, Prakken: Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60). in PLoS ONE 2011 (PubMed)
    Show all 5 Pubmed References

  3. Human Monoclonal TNFRSF8 Primary Antibody for IHC (f), FACS - ABIN2749181 : Falini, Pileri, Pizzolo, Dürkop, Flenghi, Stirpe, Martelli, Stein: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. in Blood 1995 (PubMed)
    Show all 5 Pubmed References

  4. Human Monoclonal TNFRSF8 Primary Antibody for FACS - ABIN610027 : Dayanir, Meyer, Lashkari, Rahimi: Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. in The Journal of biological chemistry 2001 (PubMed)
    Show all 2 Pubmed References

  5. Human Monoclonal TNFRSF8 Primary Antibody for FACS - ABIN4900897 : Cocco, Stephenson, Care, Newton, Barnes, Davison, Rawstron, Westhead, Doody, Tooze: In vitro generation of long-lived human plasma cells. in Journal of immunology (Baltimore, Md. : 1950) 2012 (PubMed)
    Show all 2 Pubmed References

  6. Human Monoclonal TNFRSF8 Primary Antibody for FACS, IHC (p) - ABIN192355 : Pavlov, Martins, Delgado: Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. in Clinical and vaccine immunology : CVI 2009 (PubMed)
    Show all 7 Pubmed References

  7. Human Monoclonal TNFRSF8 Primary Antibody for FACS, IHC (p) - ABIN192353 : Wright, Rumble, Duckett: CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells. in The Journal of biological chemistry 2007 (PubMed)
    Show all 7 Pubmed References

  8. Human Monoclonal TNFRSF8 Primary Antibody for FACS, IHC (p) - ABIN192354 : Zeiser, Nguyen, Hou, Beilhack, Zambricki, Buess, Contag, Negrin: Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. in Blood 2007 (PubMed)
    Show all 7 Pubmed References

  9. Human Monoclonal TNFRSF8 Primary Antibody for FACS, ELISA - ABIN969019 : Kamali, Abbasi, Farokhi, Abbasi, Fallah, Seifee, Ghadimi, Rezaie: Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. in Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2010 (PubMed)

  10. Human Monoclonal TNFRSF8 Primary Antibody for FACS, IHC (p) - ABIN94067 : Polte, Behrendt, Hansen: Direct evidence for a critical role of CD30 in the development of allergic asthma. in The Journal of allergy and clinical immunology 2006 (PubMed)
    Show all 7 Pubmed References

More Antibodies against TNFRSF8 Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. Data suggest that Brentuximab Vedotin (SGN-35) damaged CD30 ligand (CD30L (show TNFSF8 Antibodies))-immune cells through CD30 extracellular vesicles (EVs).

  2. median FoxP3 (show FOXP3 Antibodies)+ Treg count was higher in CD30+ than in CD30- posttransplant lymphoproliferative disorders, 3.0 vs 0

  3. Variant histology is common in pediatric NLPHL, especially types C and E, which are associated with IgD expression. Type C variant histology and possibly type D are associated with decreased EFS (show EFS Antibodies), but neither IgD nor CD30 are adverse features. Variant histology may warrant increased surveillance, but did not affect overall survival.

  4. Expression of CD30 in patients with both DLBCL and other aggressive B-cell lymphomas and the absence of MYC (show MYC Antibodies) oncogene (show RAB1A Antibodies)-driven proliferation in the majority of these tumors suggests that brentuximab may be a particularly effective form of targeted therapy in the subset of patients with high CD30 expression.

  5. Prevalence of the CD30 (Ki-1) antigen in human solid tumors was summarized.

  6. CD30 expression was detected in up to 25% of cases of diffuse large B-cell lymphoma and was more frequent in tumors without MYC (show MYC Antibodies) rearrangement. CD30 expression was not associated with overall survival in R-EPOCH-treated de novo DLBCL patients.

  7. CD30 facilitates phosphorylation of heat shock factor 1, activates heat shock promoter element, and induces heat shock protein (HSP) 90 (show HSP90AA1 Antibodies).

  8. this study shows that polyclonal and allogeneic stimulation induced higher levels of CD30 transcripts in end-stage renal disease patients compared to control patients

  9. CD30 expression was not associated with prognosis in our cohort of de novoDLBCL, including in patients who received aggressive chemotherapy. CD30 expression and MYC (show MYC Antibodies) rearrangement were mutually exclusive in de novoDLBCL.

  10. Case Report: CD30 positive lymphomatoid papulosis arising in association with cutaneous amyloidosis in a patient with multiple myeloma.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (show CD4 Antibodies) T cells at the induction phase of experimental autoimmune encephalomyelitis.

  2. Data indicate that CD30L (show TNFSF8 Antibodies)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).

  3. role in the maintenance and activation of IL-17A (show IL17A Antibodies)-producing gammadelta T cells

  4. These results suggest that CD30 signaling plays an important role in the activation of IL-17A (show IL17A Antibodies)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (show SLC11A1 Antibodies) infection.

  5. Interference of the CD30-CD30L (show TNFSF8 Antibodies) pathway reduces atherosclerosis development.

  6. CD30L (show TNFSF8 Antibodies)/CD30 pathway acts as an accelerator of enteritis in a murine disease model

  7. role of CD30L (show TNFSF8 Antibodies)/CD30 interactions in allergic rhinitis; results suggest that CD30L (show TNFSF8 Antibodies) plays an important role in allergic rhinitis

  8. Abrogation of CD30 and OX40 (show TNFRSF4 Antibodies) signals prevents autoimmune disease in FoxP3 (show FOXP3 Antibodies)-deficient mice.

  9. Studies demonstrate that CD30L (show TNFSF8 Antibodies)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.

  10. CD30 can signal in a completely TCR-independent fashion to induce IL-13 (show IL13 Antibodies) production by effector T cells.

TNFRSF8 Antigen Profile

Protein Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

Gene names and symbols associated with TNFRSF8

  • TNF receptor superfamily member 8 (TNFRSF8) antibody
  • tumor necrosis factor receptor superfamily, member 8 (Tnfrsf8) antibody
  • TNF receptor superfamily member 8 (Tnfrsf8) antibody
  • TNF superfamily member 8 (TNFSF8) antibody
  • Cd30 antibody
  • D1S166E antibody
  • Ki antibody
  • Ki-1 antibody
  • TNFRSF8 antibody

Protein level used designations for TNFRSF8

CD30L receptor , Ki-1 antigen , cytokine receptor CD30 , lymphocyte activation antigen CD30 , tumor necrosis factor receptor superfamily member 8 , Tumor necrosis factor superfamily member 8 , tumor necrosis factor superfamily, member CD30 , tumor necrosis factor receptor superfamily, member 8 , tumor necrosis factor ligand superfamily member 8 , tumor necrosis factor receptor superfamily member 8-like

GENE ID SPECIES
943 Homo sapiens
21941 Mus musculus
25069 Rattus norvegicus
395090 Gallus gallus
457960 Pan troglodytes
487438 Canis lupus familiaris
574055 Sus scrofa
574056 Bos taurus
614780 Bos taurus
722773 Macaca mulatta
100385465 Callithrix jacchus
100579424 Nomascus leucogenys
Selected quality suppliers for anti-TNFRSF8 (TNFRSF8) Antibodies
Did you look for something else?